Close

Analyst Ratings for Ultragenyx Pharma (RARE)

RARE Rating Summary

RARE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RARE
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $94.15 (+112.5%) * Over Last 12-Mos
Rating Score: 7.9 / 10   Percentile Rank: 83%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/8/2023 Wells Fargo N/A New Coverage Overweight
(N/A)
72.00
(N/A)
41.11
(44.30)
7.76% Details
6/14/2023 Credit Suisse Judah Frommer New Coverage Outperform
(N/A)
96.00
(N/A)
51.40
(44.30)
-13.81% Details